Commentary

Class II malocclusions, due to mandibular retrognathism, occur with high frequency and are often managed using removable functional appliances (RFAs). These appliances stimulate mandibular growth by holding it forward and have been shown to benefit growing patients. However, individual contributions of skeletal and dental changes following functional appliance therapy remain controversial. This well conducted review aims to summarise the evidence regarding effectiveness of RFAs in the treatment of Class II malocclusions, compared to untreated controls, using angular measurements from lateral cephalographs.

Two authors independently undertook an exhaustive search of the literature to include major electronic databases with no limits on language, status and year of publication. Primary authors were contacted as appropriate. Since the review was to evaluate therapeutic intervention, the authors correctly limited the included studies to randomised clinical trials (RCTs) and prospective controlled clinical trials (pCCTs). Additionally, by excluding studies without or inappropriate control (n=71), the authors increased the review's internal validity. Cochrane Collaboration's risk of bias assessment tool was used to evaluate RCTs while modified a Downs and Black checklist1 was used to evaluate pCCTs. Inter-examiner agreement, assessed by kappa statistic, was high for study selection, data extraction and risk of bias assessment.

Meta-analysis was performed using a random effects model for 15 skeletal, eight dental and five soft tissue angular measurements from lateral cephalographs. This is important because linear measurements are subject to magnification error and may bias the results.

Overall, there was a small restrictive effect on the maxilla, minimal mandibular growth, moderate improvement in maxilla-mandibular relationships and a small increase in mandibular plane angle. Significant retroclination of maxillary incisors and proclination of mandibular incisors along with favourable soft tissue changes were seen at the end of RFA therapy.

Analysis of efficacy of RFA in the treatment of Class II malocclusions is complicated by a variety of confounding factors including patient characteristics (skeletal age, sex, growth pattern) as well as appliance attributes (type, duration of wear, mechanism of action). Even though randomisation minimises these effects, a majority of the included studies (10 pCCTs) were not randomised. Of the included RCTs, only one study was assessed to be low risk of bias while one other was unclear risk of bias. This limits the external validity of the review. However, these drawbacks are related to the quality of the available literature and not reflective of the rigour of the review.

More studies are needed to clearly delineate the influence of patient compliance on treatment outcomes, especially in the context of RFA. A critical knowledge gap exists in identifying factors related to retention and long-term stability of the changes accomplished by RFA. With demonstrated significant changes in soft tissue cephalometric parameters, it will be interesting to evaluate the patient perception of effectiveness of RFA therapy.

Practice point

  • There is sufficient evidence from clinical trials to indicate that removable functional appliances are effective in treating Class II malocclusions

  • RFA treatment induced significant dentoalveolar and soft tissue changes with minimal effects on the skeleton

  • RFA can be especially advantageous in the treatment of Class II malocclusions with proclined maxillary incisors.